FDA Requests Label Change for Sleep Disorder Drug Products

On March 14, 2007, the Food and Drug Administration formally requested that all manufacturers of sedative-hypnotic drug products revise their product labeling to include stronger language concerning potential risks and communicate these potential risks to health care providers.

To read the FDA press release about this request, visit www.fda.gov/bbs/topics/NEWS/2007/NEW01587.html.

The American Academy of Sleep Medicine (AASM) prepared a statement on the use of sleep medications that can be viewed online at www.aasmnet.org/Articles.aspx?id=196.

2007-03-15T00:00:00+00:00 March 15th, 2007|Professional Development|